Edition:
United States

Kamada Ltd (KMDA.OQ)

KMDA.OQ on NASDAQ Stock Exchange Global Select Market

5.65USD
1:16pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.65
Open
$5.65
Day's High
$5.65
Day's Low
$5.65
Volume
1,255
Avg. Vol
5,294
52-wk High
$5.85
52-wk Low
$3.75

Chart for

About

No overview information found for .
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  KMDA.OQ Industry Sector
P/E (TTM): -- 29.21 33.15
EPS (TTM): -- -- --
ROI: -- 13.66 13.23
ROE: -- 15.51 15.27

BRIEF-Kamada Reports Q1 Earnings Per Share $0.03

* REAFFIRMING GUIDANCE OF $116 MILLION TO $120 MILLION IN TOTAL REVENUES FOR 2018 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

May 15 2018

BRIEF-Kamada Ltd Says Kedrab Has Been Launched In U.S.

* KAMADA LTD - KEDRAB HAS BEEN LAUNCHED IN U.S. Source text for Eikon: Further company coverage:

May 08 2018

BRIEF-Tetra Bio-Pharma Signs Landmark Commercialization Term Sheet For Its Product PPP001 In Israel

* TETRA BIO-PHARMA SIGNS LANDMARK COMMERCIALIZATION TERM SHEET FOR ITS LEAD PHARMACEUTICAL PRODUCT, PPP001, IN ISRAEL

Apr 24 2018

BRIEF-Kamada Gets Feedback From FDA On Proposed Phase 3 Protocol For Inhaled Alpha-1-Antitrypsin

* KAMADA RECEIVED FEEDBACK FROM FDA ON PROPOSED PHASE 3 PROTOCOL FOR INHALED ALPHA-1-ANTITRYPSIN FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY DISEASE

Apr 23 2018

BRIEF-Kamada Ltd Q4 Earnings Per Share $0.16

* KAMADA REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL-YEAR 2017

Feb 07 2018

Earnings vs. Estimates

No consensus analysis data available.